256 research outputs found
Young stars in the time domain
Variability is a defining characteristic of young stellar systems, and optical variability has been heavily studied to select and characterize the photospheric properties of young stars. In recent years, multi-epoch observations sampling a wider range of wavelengths and time-scales have revealed a wealth of time-variable phenomena at work during the star formation process. This splinter session was convened to summarize recent progress in providing improved coverage and understanding of time-variable processes in young stars and circumstellar disks. We begin by summarizing results from several multi-epoch Spitzer campaigns, which have demonstrated that many young stellar objects evidence significant mid-IR variability. While some of these variations can be attributed to processes in the stellar photosphere, others appear to trace short time-scale changes in the circumstellar disk which can be successfully modeled with axisymmetric or non-axisymmetric structures. We also review recent studies probing variability at shorter wavelengths that provide evidence for high frequency pulsations associated with accretion outbursts, correlated optical/X-ray variability in Classical T Tauri stars, and magnetic reversals in young solar analogs
IN-SYNC. V. Stellar kinematics and dynamics in the Orion A Molecular Cloud
The kinematics and dynamics of young stellar populations enable us to test
theories of star formation. With this aim, we continue our analysis of the
SDSS-III/APOGEE IN-SYNC survey, a high resolution near infrared spectroscopic
survey of young clusters. We focus on the Orion A star-forming region, for
which IN-SYNC obtained spectra of stars. In Paper IV we used these
data to study the young stellar population. Here we study the kinematic
properties through radial velocities (). The young stellar population
remains kinematically associated with the molecular gas, following a
gradient along filament. However, near the center
of the region, the distribution is slightly blueshifted and asymmetric;
we suggest that this population, which is older, is slightly in foreground. We
find evidence for kinematic subclustering, detecting statistically significant
groupings of co-located stars with coherent motions. These are mostly in the
lower-density regions of the cloud, while the ONC radial velocities are
smoothly distributed, consistent with it being an older, more dynamically
evolved cluster. The velocity dispersion varies along the filament.
The ONC appears virialized, or just slightly supervirial, consistent with an
old dynamical age. Here there is also some evidence for on-going expansion,
from a --extinction correlation. In the southern filament, is
-- times larger than virial in the L1641N region, where we infer a
superposition along the line of sight of stellar sub-populations, detached from
the gas. On the contrary, decreases towards L1641S, where the
population is again in agreement with a virial state.Comment: 14 pages, 13 figures, ApJ accepte
Corticosteroids in idiopathic pulmonary fibrosis (IPF)
Peer Reviewedhttp://deepblue.lib.umich.edu/bitstream/2027.42/89998/1/white-corticosteroids_idiopathic_pulmonary.pd
ALMA 1.3 Millimeter Map of the HD 95086 System
Planets and minor bodies such as asteroids, Kuiper-belt objects and comets
are integral components of a planetary system. Interactions among them leave
clues about the formation process of a planetary system. The signature of such
interactions is most prominent through observations of its debris disk at
millimeter wavelengths where emission is dominated by the population of large
grains that stay close to their parent bodies. Here we present ALMA 1.3 mm
observations of HD 95086, a young early-type star that hosts a directly imaged
giant planet b and a massive debris disk with both asteroid- and Kuiper-belt
analogs. The location of the Kuiper-belt analog is resolved for the first time.
The system can be depicted as a broad (0.84), inclined
(30\arcdeg3\arcdeg) ring with millimeter emission peaked at 2006 au
from the star. The 1.3 mm disk emission is consistent with a broad disk with
sharp boundaries from 1066 to 32020 au with a surface density
distribution described by a power law with an index of --0.50.2. Our deep
ALMA map also reveals a bright source located near the edge of the ring, whose
brightness at 1.3 mm and potential spectral energy distribution are consistent
with it being a luminous star-forming galaxy at high redshift. We set
constraints on the orbital properties of planet b assuming co-planarity with
the observed disk.Comment: accepted for publication in A
Prognostic Value of Bronchiolitis Obliterans Syndrome Stage 0-p in Single-Lung Transplant Recipients
Rationale: Early diagnosis of bronchiolitis obliterans syndrome (BOS)
is critical in understanding pathogenesis and devising therapeutic
trials. Although potential-BOS stage (BOS 0-p), encompassing early
changes in FEV1 and forced expiratory flow, midexpiratory phase
(FEF25–75%), has been proposed, there is a paucity of data validating
its utility in single-lung transplantation. Objective: The aim of this
study was to define the predictive ability of BOS 0-p in single-lung
transplantation. Methods: We retrospectively analyzed spirometric
data for 197 single-lung recipients. Sensitivity, specificity, and positive
predictive value of BOS 0-p were examined over time using
Kaplan-Meier methodology. Results: BOS 0-p FEV1 was associated
with higher sensitivity, specificity, and positive predictive value than
the FEF25–75% criterion over different time periods investigated. The
probability of testing positive for BOS 0-p FEV1 in patients with
BOS (sensitivity) was 71% at 2 years before the onset of BOS. The
probability of being free from development of BOS 0-p FEV1 in
patients free of BOS at follow-up (specificity) was 93% within the
last year. Of patients who met the BOS 0-p FEV1 criterion, 81%
developed BOS or died within 3 years. The specificity and positive
predictive value curves for the BOS 0-p FEV1 were significantly different
between patients with underlying restrictive versus obstructive
physiology (p = 0.05 and 0.01, respectively). Conclusion: The FEV1
criterion for BOS 0-p provides useful predictive information regarding
the risk of development of BOS or death in single-lung recipients.
The predictive value of this criterion is higher in patients with
underlying restriction and is superior to the FEF25–75% criterion.Supported in part by National Institutes of Health grants K23 HL077719 and
K24HL04212 and American Lung Association RG-1059-N.Peer Reviewedhttp://deepblue.lib.umich.edu/bitstream/2027.42/91970/1/2005 AJRCCM - Prognostic Value of Bronchiolitis Obliterans Syndrome Stage 0-p in Single-Lung Transplant Recipients.pd
Effects of nintedanib on symptoms in patients with progressive pulmonary fibrosis
BACKGROUND: Dyspnoea and cough can have a profound impact on the lives of patients with pulmonary fibrosis. We investigated the effects of nintedanib on the symptoms and impact of pulmonary fibrosis in patients with progressive pulmonary fibrosis (PPF) in the INBUILD trial using the Living with Pulmonary Fibrosis (L-PF) questionnaire. METHODS: Patients had a fibrosing interstitial lung disease (ILD) (other than idiopathic pulmonary fibrosis) of >10% extent on high-resolution computed tomography (HRCT) and met criteria for ILD progression within the prior 24 months. Patients were randomised 1:1 to receive nintedanib or placebo. Changes in L-PF questionnaire scores from baseline to week 52 were assessed using mixed models for repeated measures. RESULTS:In total, 663 patients were treated. Compared with placebo, there were significantly smaller increases (worsenings) in adjusted mean L-PF questionnaire total (0.5 versus 5.1), symptoms (1.3 versus 5.3), dyspnoea (4.3 versus 7.8) and fatigue (0.7 versus 4.0) scores in the nintedanib group at week 52. L-PF questionnaire cough score decreased in the nintedanib group and increased in the placebo group (-1.8 versus 4.3). L-PF questionnaire impacts score decreased slightly in the nintedanib group and increased in the placebo group (-0.2 versus 4.6). Similar findings were observed in patients with a usual interstitial pneumonia-like fibrotic pattern on HRCT and in patients with other fibrotic patterns on HRCT.CONCLUSION: Based on changes in L-PF questionnaire scores, nintedanib reduced worsening of dyspnoea, fatigue and cough and the impacts of ILD over 52 weeks in patients with PPF.</p
- …